Benign Prostatic Hyperplasia (BPH), also commonly known as prostate enlargement, is a non-cancerous enlargement of the prostate gland. It is one of the most common urological problems in elderly males, with a 40% incidence for those above 60 years old. This incidence increases with age.
Some of the common symptoms of BPH include difficulty in starting urination, a weak urinary stream, interruption of the stream, a sensation of incomplete bladder emptying, and urgent and frequent urination.
The therapeutic options for BPH range from medical management to invasive surgery. Transurethral resection of the prostate (TURP) remains the gold standard in managing BPH, but advances in technology have increased the number of minimally invasive surgery options, of which UroLift and Rezum are two new options.
Indications for TURP: